| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C0020974> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C0021022> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C0028380> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C0242348> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C0475463> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C0600249> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C0600250> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33492637_HAS_TOPIC_C5444125>
?:authorAffiliation	[\'Clinical Immunology and Rheumatology, Nizam\'s Institute of Medical Sciences (NIMS), Hyderabad, India.\', \'Clinical Immunology and Rheumatology, Nizam\'s Institute of Medical Sciences (NIMS), Hyderabad, India. lizarajasekhar@gmail.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Baisya_Ritasman> <https://research.tib.eu/covid-19/entity/Devarasetti_Phani_Kumar> <https://research.tib.eu/covid-19/entity/Rajasekhar_Liza> <https://research.tib.eu/covid-19/entity/Sreejitha_K_S> <https://research.tib.eu/covid-19/entity/Vardhan_Yerram_Keerthi>
?:doi	<https://research.tib.eu/covid-19/entity/10.1007/s12026-020-09169-x>
?:doi	10.1007/s12026-020-09169-x
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Immunologic research
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33492637>
?:pmid	<https://research.tib.eu/covid-19/entity/33492637>
?:pmid	33492637
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.198
?:rankingScore_hIndex	74
?:title	A review of COVID-19 convalescent plasma use in COVID-19 with focus on proof of efficacy.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33492637>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33492637>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all